Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/32869
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Norman, R. | - |
dc.contributor.author | De Lacey, S. | - |
dc.contributor.author | Wang, J. | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | Reproductive Biomedicine Online, 2005; 11(5):542-543 | - |
dc.identifier.issn | 1472-6483 | - |
dc.identifier.issn | 1472-6491 | - |
dc.identifier.uri | http://hdl.handle.net/2440/32869 | - |
dc.description.abstract | The Australian experience of gonadotrophin stimulation is a useful example of steps that lead to a country deciding to use recombinant FSH solely. | - |
dc.description.statementofresponsibility | R.J. Norman, S. De Lacey and J.X. Wang | - |
dc.language.iso | en | - |
dc.publisher | Reproductive Healthcare Ltd. | - |
dc.rights | © Reproductive BioMedicine Online | - |
dc.source.uri | http://dx.doi.org/10.1016/s1472-6483(10)61157-1 | - |
dc.subject | Follicle-stimulating hormone | - |
dc.subject | Gonadotropin | - |
dc.subject | pituitary hormones | - |
dc.subject | recombinant FSH | - |
dc.title | Recombinant or urinary gonadotrophins - an Australian perspective | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/S1472-6483(10)61157-1 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Norman, R. [0000-0002-3118-3896] | - |
Appears in Collections: | Aurora harvest 6 Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.